MacIej Cabanski

Maciej Cabanski currently serves as Senior Director of Biomarkers and CDx at Monte Rosa Therapeutics since November 2021, following a tenure as Director in the same field. Prior experience includes roles at Novartis Institutes for BioMedical Research, where Maciej worked as a Clinical Biomarker Expert from January 2015 to November 2021, focusing on biomarker strategies for clinical studies. Maciej's career also encompasses positions at Philip Morris International as an Associate Staff Scientist, leading R&D projects related to smoking-related diseases, and as a Postdoctoral Research Fellow at Hannover Medical School. Academic qualifications include a Ph.D. in Molecular Biology & Immunology from Justus Liebig University and an MSc in Molecular Biology & Biotechnology from Adam Mickiewicz University.